These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9850229)

  • 1. Economic burden of drug dependency. Social costs incurred by drug users at intake to the National Treatment Outcome Research Study.
    Healey A; Knapp M; Astin J; Gossop M; Marsden J; Stewart D; Lehmann P; Godfrey C
    Br J Psychiatry; 1998 Aug; 173():160-5. PubMed ID: 9850229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimation of the Social Costs of Illegal Drug Use in Poland Using Standardized Methodology.
    Mielecka-Kubie ZJ
    J Ment Health Policy Econ; 2020 Sep; 23(3):139-149. PubMed ID: 33411676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic analysis of costs and consequences of the treatment of drug misuse: 2-year outcome data from the National Treatment Outcome Research Study (NTORS).
    Godfrey C; Stewart D; Gossop M
    Addiction; 2004 Jun; 99(6):697-707. PubMed ID: 15139868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substance use, health and social problems of service users at 54 drug treatment agencies. Intake data from the National Treatment Outcome Research Study.
    Gossop M; Marsden J; Stewart D; Lehmann P; Edwards C; Wilson A; Segar G
    Br J Psychiatry; 1998 Aug; 173():166-71. PubMed ID: 9850230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The social cost of illicit drugs use in Spain.
    Rivera B; Casal B; Currais L
    Int J Drug Policy; 2017 Jun; 44():92-104. PubMed ID: 28475905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reductions in criminal convictions after addiction treatment: 5-year follow-up.
    Gossop M; Trakada K; Stewart D; Witton J
    Drug Alcohol Depend; 2005 Sep; 79(3):295-302. PubMed ID: 16102373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The socioeconomic impact of drug-related crimes in Chile.
    Fernández M
    Int J Drug Policy; 2012 Nov; 23(6):465-72. PubMed ID: 22608568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Criminal outcomes and costs of treatment services for injecting and non-injecting heroin users: evidence from a national prospective cohort survey.
    Healey A; Knapp M; Marsden J; Gossop M; Stewart D
    J Health Serv Res Policy; 2003 Jul; 8(3):134-41. PubMed ID: 12869338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The social cost of illegal drug consumption in Spain.
    García-Altés A; Ollé JM; Antoñanzas F; Colom J
    Addiction; 2002 Sep; 97(9):1145-53. PubMed ID: 12199830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The costs of alcohol, illegal drugs, and tobacco in Canada, 2002.
    Rehm J; Gnam W; Popova S; Baliunas D; Brochu S; Fischer B; Patra J; Sarnocinska-Hart A; Taylor B
    J Stud Alcohol Drugs; 2007 Nov; 68(6):886-95. PubMed ID: 17960307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary estimates of the economic implications of addiction in the United Arab Emirates.
    Doran CM
    East Mediterr Health J; 2017 Jan; 22(10):749-755. PubMed ID: 28134427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The National Treatment Outcomes Research Study (NTORS) and its influence on addiction treatment policy in the United Kingdom.
    Gossop M
    Addiction; 2015 Jul; 110 Suppl 2():50-3. PubMed ID: 26042569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unique Characteristics of High-Cost Users of Medical Care With Comorbid Mental Illness or Addiction in a Population-Based Cohort.
    Hensel JM; Taylor VH; Fung K; de Oliveira C; Vigod SN
    Psychosomatics; 2018; 59(2):135-143. PubMed ID: 29157683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Social costs of illegal drugs, alcohol and tobacco in the European Union: A systematic review.
    Barrio P; Reynolds J; García-Altés A; Gual A; Anderson P
    Drug Alcohol Rev; 2017 Sep; 36(5):578-588. PubMed ID: 28334460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Legislations and policies to expand mental health and substance abuse benefits in health insurance plans: a community guide systematic economic review.
    Jacob V; Qu S; Chattopadhyay S; Sipe TA; Knopf JA; Goetzel RZ; Finnie R; Thota AB;
    J Ment Health Policy Econ; 2015 Mar; 18(1):39-48. PubMed ID: 25862203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost of depression in Europe.
    Sobocki P; Jönsson B; Angst J; Rehnberg C
    J Ment Health Policy Econ; 2006 Jun; 9(2):87-98. PubMed ID: 17007486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can we model the impact of increased drug treatment expenditure on the U.K. drug market?
    Godfrey C; Parrott S; Eaton G; Culyer A; McDougall C
    Adv Health Econ Health Serv Res; 2005; 16():257-75. PubMed ID: 17867243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The five-year costs and benefits of extended psychological and psychiatric assessment versus standard intake interview for women with comorbid substance use disorders treated in compulsory care in Sweden.
    Olsson TM; Fridell M
    BMC Health Serv Res; 2018 Jan; 18(1):53. PubMed ID: 29378568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefit-cost in the California treatment outcome project: does substance abuse treatment "pay for itself"?
    Ettner SL; Huang D; Evans E; Ash DR; Hardy M; Jourabchi M; Hser YI
    Health Serv Res; 2006 Feb; 41(1):192-213. PubMed ID: 16430607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Costs of criminal justice involvement among persons with serious mental illness in connecticut.
    Swanson JW; Frisman LK; Robertson AG; Lin HJ; Trestman RL; Shelton DA; Parr K; Rodis E; Buchanan A; Swartz MS
    Psychiatr Serv; 2013 Jul; 64(7):630-7. PubMed ID: 23494058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.